Exploring the multifocal role of phytochemicals as immunomodulators T Behl, K Kumar, C Brisc, M Rus, DC Nistor-Cseppento, C Bustea, ... Biomedicine & Pharmacotherapy 133, 110959, 2021 | 136 | 2021 |
Aspects regarding the pharmaceutical waste management in Romania S Bungau, DM Tit, K Fodor, G Cioca, M Agop, C Iovan, DCN Cseppento, ... Sustainability 10 (8), 2788, 2018 | 99 | 2018 |
Oxidative stress–Complex pathological issues concerning the hallmark of cardiovascular and metabolic disorders D Rotariu, EE Babes, DM Tit, M Moisi, C Bustea, M Stoicescu, AF Radu, ... Biomedicine & Pharmacotherapy 152, 113238, 2022 | 92 | 2022 |
Polyphenols targeting MAPK mediated oxidative stress and inflammation in rheumatoid arthritis T Behl, T Upadhyay, S Singh, S Chigurupati, AM Alsubayiel, V Mani, ... Molecules 26 (21), 6570, 2021 | 77 | 2021 |
Long‐term resveratrol supplementation as a secondary prophylaxis for stroke K Fodor, DM Tit, B Pasca, C Bustea, D Uivarosan, L Endres, C Iovan, ... Oxidative medicine and cellular longevity 2018 (1), 4147320, 2018 | 75 | 2018 |
Cross-talks among GBA mutations, glucocerebrosidase, and α-synuclein in GBA-associated Parkinson’s disease and their targeted therapeutic approaches: a … T Behl, G Kaur, O Fratila, C Buhas, CT Judea-Pusta, N Negrut, C Bustea, ... Translational neurodegeneration 10, 1-13, 2021 | 59 | 2021 |
Interactions between leptin and insulin resistance in patients with prediabetes, with and without NAFLD S Bungau, T Behl, DM Tit, F Banica, OG Bratu, CC Diaconu, ... Experimental and therapeutic medicine 20 (6), 1-1, 2020 | 45 | 2020 |
Acute coronary syndromes in diabetic patients, outcome, revascularization, and antithrombotic therapy EE Babes, C Bustea, T Behl, MM Abdel-Daim, AC Nechifor, M Stoicescu, ... Biomedicine & Pharmacotherapy 148, 112772, 2022 | 39 | 2022 |
Non-alcoholic fatty liver disease and cardiovascular comorbidities: pathophysiological links, diagnosis, and therapeutic management A Jichitu, S Bungau, AMA Stanescu, CM Vesa, MM Toma, C Bustea, ... Diagnostics 11 (4), 689, 2021 | 39 | 2021 |
No-reflow after PPCI—A predictor of short-term outcomes in STEMI patients LR Pantea-Roșan, VA Pantea, S Bungau, DM Tit, T Behl, CM Vesa, ... Journal of clinical medicine 9 (9), 2956, 2020 | 39 | 2020 |
Prediction of NAFLD occurrence in prediabetes patients CM Vesa, T Behl, S Nemeth, OG Bratu, CC Diaconu, RD Moleriu, ... Experimental and Therapeutic Medicine 20 (6), 1-1, 2020 | 28 | 2020 |
Risk Factors Associated with Recurrent Clostridioides difficile Infection N Negrut, S Bungau, T Behl, SA Khan, CM Vesa, C Bustea, ... Healthcare 8 (3), 352, 2020 | 28 | 2020 |
Chemo-preventive action of resveratrol: suppression of p53—a molecular targeting approach R Akter, MH Rahman, D Kaushik, V Mittal, D Uivarosan, AC Nechifor, ... Molecules 26 (17), 5325, 2021 | 22 | 2021 |
Framing cause-effect relationship of acute coronary syndrome in patients with chronic kidney disease MI Moisi, SG Bungau, CM Vesa, CC Diaconu, T Behl, M Stoicescu, ... Diagnostics 11 (8), 1518, 2021 | 21 | 2021 |
Arterial function in hypertensive pregnant women. Is arterial stiffness a marker for the outcomes in pregnancy? V Turi, S Iurciuc, OM Crețu, DM Tit, S Bungau, A Apostol, RD Moleriu, ... Life sciences 264, 118723, 2021 | 17 | 2021 |
Myocardial viability testing in the management of ischemic heart failure EE Babes, DM Tit, AF Bungau, C Bustea, M Rus, SG Bungau, VV Babes Life 12 (11), 1760, 2022 | 9 | 2022 |
A narrative review of the classical and modern diagnostic methods of the no-reflow phenomenon LR Pantea-Roșan, SG Bungau, AF Radu, VA Pantea, MI Moisi, CM Vesa, ... Diagnostics 12 (4), 932, 2022 | 9 | 2022 |
Green synthesis of silver nanoparticles using Hypericum perforatum L. extract and evaluation of their antibacterial activity D Gitea, A Teodorescu, C Pantis, DM Tit, AF Bungau, M Bogdan, IK Fodor, ... Rev. Chim 71, 273-279, 2020 | 8 | 2020 |
Exploring the molecular pathways and therapeutic implications of angiogenesis in neuropathic pain A Sharma, T Behl, L Sharma, OP Shah, S Yadav, M Sachdeva, S Rashid, ... Biomedicine & Pharmacotherapy 162, 114693, 2023 | 6 | 2023 |
Left ventricle outflow tract velocity-time index and right ventricle to left ventricle ratio as predictors for in hospital outcome in intermediate-risk pulmonary embolism EE Babes, M Stoicescu, SG Bungau, D Uivarosan, DM Tit, MM Toma, ... Diagnostics 12 (5), 1226, 2022 | 6 | 2022 |